ACR Convergence 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences

GSK at ACR Convergence 2026

Nov 6–11, 2026 Orlando, FL ~15k attendees Website

GSK brings 6 presentations to ACR Convergence 2026 in Orlando, and exhibits at Booth 2615. Its program centres on lupus, including earlier treatment to prevent progression, belimumab outcomes and lupus nephritis, along with B cell biology in systemic sclerosis skin and patient experience with EGPA treatment.

OrganizationACR Convergence 2026 Attendance
GSK
Durham, NC
Pharmaceutical companies
Global pharmaceutical company developing and marketing medicines and vaccines.
Booth
Exhibiting at Booth 2615
Sun, Nov 810:00am–5:00pmMon, Nov 910:00am–5:00pmTue, Nov 1010:00am–2:30pm
Industry
Sun Nov 8
5:30pm–7:30pm
Preventing Progression in Lupus: Are You Intervening Early Enough?
Hyatt Regency Orlando, Regency Ballroom Q
Lupus · with Hospital for Special Surgery, University of California, San Francisco
Industry
Mon Nov 9
12:30pm–1:15pm
Clinical Insights in Lupus and LN: Revisiting Long-Standing Perceptions with Emerging Evidence
Innovation Theater A
Lupus · with Washington University in St. Louis, The Ohio State University

Explore the full ACR Convergence 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Orlando. Leave your work email and we’ll be in touch.

Privacy

Download the full ACR Convergence 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at GSK

Tell us what you sell and we’ll find the people at GSK most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the American College of Rheumatology (ACR). Organization details are derived from the ACR’s published program and exhibitor floor plan, and each organization’s own website. Submit a correction